# Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease

> **NCT03801928** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 118 (actual)

## Conditions studied

- Inflammatory Bowel Disease (IBD)
- Crohn's Disease (CD)
- Ulcerative Colitis (UC)

## Interventions

- **DRUG:** Inflectra

## Key facts

- **NCT ID:** NCT03801928
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-23
- **Primary completion:** 2020-02-07
- **Final completion:** 2020-02-07
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2021-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03801928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03801928, "Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03801928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*